Hexose-6-phosphate Dehydrogenase Knock-out Mice Lack 11β-Hydroxysteroid Dehydrogenase Type 1-mediated Glucocorticoid Generation
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The local generation of active glucocorticoid by NADPH-dependent, 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) oxoreductase activity, has emerged as an important factor in regulating hepatic glucose output and visceral adiposity. We have proposed that this NADPH is generated within the endoplasmic reticulum by the enzyme hexose-6-phosphate dehydrogenase. To address this hypothesis, we generated mice with a targeted inactivation of the H6PD gene. These mice were unable to convert 11-dehydrocorticosterone (11-DHC) to corticosterone but demonstrated increased corticosterone to 11-DHC conversion consistent with lack of 11beta-HSD1 oxoreductase and a concomitant increase in dehydrogenase activity. This increased corticosterone clearance in the knock-out mice resulted in a reduction in circulating corticosterone levels. Our studies define the critical requirement of hexose-6-phosphate dehydrogenase for 11beta-HSD1 oxoreductase activity and add a new dimension to the investigation of 11beta-HSD1 as a therapeutic target in patients with the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations of H6PDH in patients (594) or knockout of the H6PDH gene in mice (595) appear to be both necessary and sufficient to cause this disorder.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [595]
In the citing paper
“Inactivation of H6PDH in mice and humans leads not only to the loss of 11β-HSD1 oxo-reductase activity but also to a gain of 11β-HSD1 dehydrogenase activity, with a profound switch to cortisol inactivation (4, 12) .”
From Novel H6PDH mutations in two girls with premature adrenarche: ‘apparent’ and ‘true’ CRD can be differentiated by urinary steroid profiling (2013) · cites this paper as [12]
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citationKotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Self-citationMorton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 439
Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434
Paterson, J. M., Morton, N. M., Fievet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 431
Draper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Self-citationAlberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263
Research works printed but not linked: 1
- White, 1997, Endocr. Rev., 18, 135
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
“Loss of H6PDH leads to reaction reversal of 11 -HSD1, although the physiological relevance remains uncertain (389, 391).”
BackgroundBÁNHEGYI, G., BAUMEISTER, P., BENEDETTI, A., DONG, D., FU, Y., LEE, A. S., LI, J., MAO, C., MARGITTAI, É., NI, M., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1391.007 · Cited by 262
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease
Odermatt, A. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2011 · Cited by 257
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
“der most physiological circumstances [143,144].”
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Self-citationMorgan, S. A., Sherlock, M., Gathercole, L. L., Lavery, G. G., Lenaghan, C., Bujalska, I. J., Laber, D., Yu, A., Convey, G., Mayers, R., et al. (2009) · Diabetes · doi:10.2337/db09-0525 · Cited by 167
“Decreases in H6PDH expression and activity decrease 11!-HSD1 oxo-reductase and increase dehydrogenase activity (5).”
Self-citationMorton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Odermatt, A., & Kratschmar, D. V. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.020 · Cited by 159
Premature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
Self-citation11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · Frontiers of Hormone Research · doi:10.1159/000115363 · Cited by 134
Tomlinson, J. W., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 131
“Decreases in H6PDH expression and activity decrease oxoreductase and increase dehydrogenase activity (12,13).”
BackgroundSelf-citationEndoplasmic reticulum: A metabolic compartment
Csala, M., Bánhegyi, G., & Benedetti, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.050 · Cited by 125
“Nevertheless, H6PDH knockout mice lack 11bHSDH1 mediated glucocorticoid generation [11], which proves that the enzyme cannot rely on cytosolic NADPH resources and a separate luminal pyridine nucleotide”
BackgroundCheung, Y. Y., Kim, S. Y., Yiu, W. H., Pan, C., Jun, H.-S., Ruef, R. A., Lee, E. J., Westphal, H., Mansfield, B. C., & CHOU, J. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30443 · Cited by 133
“The resulting low G6P concentration in the ER lumen not only deprives the ER of G6P hydrolase activity, but also affects another major metabolic pathway in neutrophils: the endoluminal pentose phosphate pathway, which generates NADPH (45, 46).”
BackgroundCortisol metabolism in hypertension
Hammer, F., & Stewart, P. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.001 · Cited by 143
Self-citationA Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
Ahmed, A., Rabbitt, E., Brady, T., Brown, C., Guest, P., Bujalska, I. J., Doig, C., Newsome, P. N., Hubscher, S., Elias, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029531 · Cited by 115
“Human liver microsomes were prepared from 4 human normal livers and 5 livers with NASH livers by differential centrifugation techniques as described previously [21].”
MethodSelf-citationEndoplasmic reticulum: nutrient sensor in physiology and pathology
Mandl, J., Mészáros, T., Bánhegyi, G., Hunyady, L., & Csala, M. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.01.003 · Cited by 123
Schuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 124
Hughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
“Some concerns have been expressed about whether 11 β -HSD1 inhibition will always lower intracellular cortisol concentrations following the description of potential reversibility of enzyme activity in mice with hexose-6phosphate dehydrogenase (H6PDH) deficiency [123] .”
Lavery, G. G., Walker, E. A., Turan, N., Rogoff, D., Ryder, J. W., Shelton, J. M., Richardson, J. A., Falciani, F., White, P. C., Stewart, P. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710067200 · Cited by 99
Self-citationRapid mechanisms of glucocorticoid signaling in the Leydig cell☆
Hu, G., Lian, Q., Lin, H., LATIF, S., Morris, D. J., Hardy, M. P., & GE, R. (2008) · Steroids · doi:10.1016/j.steroids.2007.12.020 · Cited by 104
Tomlinson, J. W., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W., Courtney, R., Rejto, P., Carley, W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Self-citationLavery, G. G., Walker, E. A., Tiganescu, A., Ride, J. P., Shackleton, C. H. L., Tomlinson, J. W., Connell, J. M. C., Ray, D. W., Biason-Lauber, A., Malunowicz, E. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0743 · Cited by 95
“In humans, this implies that without NADPH, 11-HSD1 may be inactive or indeed switched from reductase to dehydrogenase activity; the H6PDH enzyme thereforerepresentsacandidatetoexplainCRD.Insupportofthis,we have demonstrated that H6PDH-null mice lose 11-HSD1 reductase activity but gain dehydrogenase activity through c…”
BackgroundSelf-citationJun, H. S., Lee, Y., Cheung, Y. Y., McDermott, D. H., Murphy, P. M., Ravin, S. S. D., Mansfield, B. C., & CHOU, J. Y. (2010) · Blood · doi:10.1182/blood-2009-12-258491 · Cited by 98
Kratschmar, D. V., Calabrese, D., Walsh, J., Lister, A., Birk, J., Appenzeller-Herzog, C., Moulin, P., Goldring, C. E., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036774 · Cited by 92
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib
Kim, S. Y., Jun, H. S., Mead, P., Mansfield, B. C., & CHOU, J. Y. (2008) · Blood · doi:10.1182/blood-2007-12-129114 · Cited by 95
“Hydrolysis of G6P by hexose-6phosphate dehydrogenase (50, 51) generates NADPH which regulates the activity of 11βhydroxysteroid dehydrogenase-1 (52).”
BackgroundRedox Control of Endoplasmic Reticulum Function
Csala, M., Margittai, É., & Bánhegyi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2529 · Cited by 98
The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response
Chapman, K. E., Coutinho, A. E., Gray, M., Gilmour, J. S., Savill, J., & Seckl, J. R. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.031 · Cited by 95
“More recently, mice have also been generat ed which are deficient in hexose-6-phosphate dehydrogenase, the “partner” enzyme to 11β-HSD1 that dictates its enzyme direction through cofactor supply within the endopl asmic reticulum lumen (Lavery et al., 2006).”
BackgroundInfluentialCarbonyl reduction pathways in drug metabolism
Malátková, P., & Wsól, V. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.853078 · Cited by 88
“The main determinant of the direction of 11b-HSD1-catalyzed reactions seems to be the availability of NADPH provided by hexose-6phosphate dehydrogenase in the lumen of endoplasmic reticulum (Atanasov et al., 2004; Lavery et al., 2006).”
BackgroundTargeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 90
Self-citation11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents
Boyle, C. D., & Kowalski, T. J. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902967658 · Cited by 74
“In vitro biochemical characterization shows that 11β-HSD1 is an NADPHdependent bidirectional enzyme that can function as both a reductase and a dehydrogenase [12]; however, the reductase activity predominates in vivo owing to the redox potential maintained by the NADPH-generating enzyme hexose6-phosphate dehydrogenase…”
Chapman, K. E., Coutinho, A. E., Gray, M., Gilmour, J. S., Savill, J., & Seckl, J. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.030 · Cited by 89
DHEA Induces 11β-HSD2 by Acting on CCAAT/Enhancer-Binding Proteins
Balazs, Z., Schweizer, R. A. S., Frey, F. J., Rohner-Jeanrenaud, F. C., & Odermatt, A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030263 · Cited by 72
Alberti, L., Girola, A., Gilardini, L., Conti, A., Cattaldo, S., Micheletto, G., & Invitti, C. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803677 · Cited by 77
Lavery, G. G., Zielinska, A. E., Gathercole, L. L., Hughes, B., Semjonous, N., Guest, P., Saqib, K., Sherlock, M., Reynolds, G., Morgan, S. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1019 · Cited by 69
Self-citationEnvironmental Pollutants and Hydroxysteroid Dehydrogenases
Ye, L., Guo, J., & Ge, R. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800095-3.00013-4 · Cited by 73
Gomez-Sanchez, E. P., Romero, D. G., de Rodriguez, A. F., Warden, M. P., Krozowski, Z., & Gomez-Sanchez, C. E. (2008) · Endocrinology · doi:10.1210/en.2007-0328 · Cited by 66
Hughes, K. A., Manolopoulos, K. N., Iqbal, J., Cruden, N. L., Stimson, R. H., Reynolds, R. M., Newby, D. E., Andrew, R., Karpe, F., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-1345 · Cited by 64
Swali, A., Walker, E. A., Lavery, G. G., Tomlinson, J., & Stewart, P. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1137-2 · Cited by 69
Self-citationDzyakanchuk, A. A., Balázs, Z., Nashev, L. G., Amrein, K. E., & Odermatt, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.009 · Cited by 73
Lawson, A. J., Walker, E. A., Lavery, G. G., Bujalska, I. J., Hughes, B., Arlt, W., Stewart, P. M., & Ride, J. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014934108 · Cited by 61
“Eachmutation abolished H6PDH activity and resulted in a lack of NADPH cofactor to support the ketoreductase activity of 11βHSD1 (20).”
BackgroundInfluentialSelf-citationTulipano, G., Rizzetti, C., Bianchi, I., Fanzani, A., Spano, P., & Cocchi, D. (2007) · Neuroendocrinology · doi:10.1159/000100981 · Cited by 60
Hexose-6-phosphate dehydrogenase in the endoplasmic reticulum
Senesi, S., Csala, M., Marcolongo, P., Fulceri, R., Mandl, J., Bánhegyi, G., & Benedetti, A. (2009) · Biological Chemistry · doi:10.1515/bc.2009.146 · Cited by 64
Walker, E. A., Ahmed, A., Lavery, G. G., Tomlinson, J. W., Kim, S. Y., Cooper, M. S., Ride, J. P., Hughes, B. A., Shackleton, C. H. L., McKiernan, P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704144200 · Cited by 59
Self-citationAlternatively spliced isoforms of WT1 control podocyte-specific gene expression
Lefebvre, J., Clarkson, M. J., Massa, F., Bradford, S. T., Charlet, A., Buske, F. A., Lacas‐Gervais, S., Schulz, H., Gimpel, C., Hata, Y., et al. (2015) · Kidney International · doi:10.1038/ki.2015.140 · Cited by 64
Iwasaki, Y., Takayasu, S., Nishiyama, M., Tsugita, M., Taguchi, T., Asai, M., Yoshida, M., Kambayashi, M., & Hashimoto, K. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.012 · Cited by 60
Insulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1
Balachandran, A., Guan, H., Sellan, M. E., Uum, S. H. M. V., & Yang, K. (2008) · Endocrinology · doi:10.1210/en.2008-0088 · Cited by 68
Guo, C., Li, C., Myatt, L., Nathanielsz, P. W., & Sun, K. (2013) · Diabetes · doi:10.2337/db12-0561 · Cited by 57
Wake, D. J., Homer, N. Z. M., Andrew, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0819 · Cited by 57
“Stewart and colleagues (24, 25) have recently proposed that variations in supply of NADPH cofactor for 11HSD1 by H6PDH may limit the capacity for reductase activity (regenerating cortisol from cortisone), allowing a switch in favor of dehydrogenase inactivation of cortisol by 11HSD1.”
BackgroundModulation of glucocorticoid action and the treatment of type-2 diabetes
Tomlinson, J., & Stewart, P. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.003 · Cited by 59
Self-citationAtanasov, A. G., Nashev, L. G., Gelman, L., Legeza, B., Sack, R., Portmann, R., & Odermatt, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.03.001 · Cited by 58
“H6PDH-deficientmice show abnormal glucose homeostasis and disturbances in the hypothalamic–pituitary–adrenal axis [26,36,37].”
BackgroundBánhegyi, G., Benedetti, A., Csala, M., & Mandl, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.028 · Cited by 55
“H6PDH knockout mice lack 11bHSD1 mediated glucocorticoid generation [30], which proves that the enzyme cannot rely on cytosolic NADPH resources and that a separate luminal pyridine nucleotide pool must exist [31,32].”
BackgroundWalker, B. R. (2007) · Proceedings of the Nutrition Society · doi:10.1017/s002966510700523x · Cited by 54
“In hexose-6phosphate dehydrogenase-deficient mice this situation results in a ‘switch’ of 11b-HSD1 to the dehydrogenase direction (Lavery et al. 2006).”
BackgroundJun, H. S., Lee, Y., Song, K., Mansfield, B. C., & CHOU, J. Y. (2011) · Blood · doi:10.1182/blood-2010-08-302059 · Cited by 53
Liu, Y., Nakagawa, Y., Wang, Y., Liu, L., Du, H., Wang, W., Ren, X., Lutfy, K., & Friedman, T. C. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0004 · Cited by 53
“Similarly, hepatic 11β-HSD1 reductase activity was impaired in H6PDH knockout mice through inactivation of local NADPH regeneration and these mutant mice exhibited fasting hypoglycemia (Lavery et al. 2006).”
BackgroundSemjonous, N. M., Sherlock, M., Jeyasuria, P., Parker, K. L., Walker, E. A., Stewart, P. M., & Lavery, G. G. (2011) · Endocrinology · doi:10.1210/en.2010-0957 · Cited by 51
“H(3)-11-DHC was synthesized in-house from H(3)-corticosterone as previously described (6, 20).”
BackgroundMethodInfluentialSelf-citationLavery, G. G., Idkowiak, J., Sherlock, M., Bujalska, I., Ride, J. P., Saqib, K., Hartmann, M. F., Hughes, B., Wudy, S. A., De Schepper, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0628 · Cited by 50
Self-citationTeofilović, A., Bursać, B. N., Djordjevic, A. D., Milutinović, D. V., Nikolič, M., Matić, G. M., & Veličković, N. A. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0641-4 · Cited by 56
“As a possible consequence of this alteration, 11bHSD1 enzyme activity could be switched from oxidoreductase to dehydrogenase, thus leading to glucocorticoid inactivation [46].”
BackgroundRogoff, D., Ryder, J. W., Black, K., Yan, Z., Burgess, S. C., McMillan, D. R., & White, P. C. (2007) · Endocrinology · doi:10.1210/en.2007-0593 · Cited by 55
Self-citation11β-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth
Wang, W., Chen, Z., Myatt, L., & Sun, K. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00188 · Cited by 52
Hexose-6-phosphate dehydrogenase: linking endocrinology and metabolism in the endoplasmic reticulum
Bánhegyi, G., Csala, M., & Benedetti, A. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0156 · Cited by 55
Fenton, C. G., Doig, C. L., Fareed, S., Naylor, A. J., Morrell, A. P., Addison, O., Wehmeyer, C., Buckley, C. D., Cooper, M. S., Lavery, G. G., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1972-1 · Cited by 53
Self-citation11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Morgan, S., & Tomlinson, J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.504713 · Cited by 51
Gambineri, A., Tomassoni, F., Munarini, A., Stimson, R. H., Mioni, R., Pagotto, U., Chapman, K. E., Andrew, R., Mantovani, V., Pasquali, R., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0091 · Cited by 55
Clinical and Basic Aspects of Glucocorticoid Action in Bone
Kream, B. E., Graves, L., & Lukert, B. P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00061-6 · Cited by 47
Redox‐based endoplasmic reticulum dysfunction in neurological diseases
Bánhegyi, G., Mandl, J., & Csala, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05571.x · Cited by 51
Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism
White, P. C., Rogoff, D., McMillan, D. R., & Lavery, G. G. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.022 · Cited by 50
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript Studies of mice lacking H6PD activity To further elucidate the biological role(s) of H6PD, a null mutation was created in the murine H6PD gene via homologous recombination (Lavery et al., 2006).”
BackgroundMethodInfluentialSelf-citationOdermatt, A., & Nashev, L. G. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.01.007 · Cited by 51
Nashev, L. G., Chandsawangbhuwana, C., Balazs, Z., Atanasov, A. G., Dick, B., Frey, F. J., Baker, M. E., & Odermatt, A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000561 · Cited by 42
Hepatic 11beta‐HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis
Konopelska, S., Kienitz, T., Hughes, B., Pirlich, M., Bauditz, J., Lochs, H., Strasburger, C. J., Stewart, P. M., & Quinkler, M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03358.x · Cited by 41
Self-citationIsocitrate dehydrogenase: A NADPH-generating enzyme in the lumen of the endoplasmic reticulum
Margittai, É., & Bánhegyi, G. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.12.017 · Cited by 41
Lack of Hexose-6-Phosphate Dehydrogenase Impairs Lipid Mobilization from Mouse Adipose Tissue
Bujalska, I. J., Hewitt, K., Hauton, D., Lavery, G. G., Tomlinson, J., Walker, E. A., & Stewart, P. M. (2008) · Endocrinology · doi:10.1210/en.2007-1705 · Cited by 44
Self-citationFructose promotes the differentiation of 3T3‐L1 adipocytes and accelerates lipid metabolism
Legeza, B., Balázs, Z., & Odermatt, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.014 · Cited by 42
Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium
Gray, G. A., White, C. I., Castellan, R. F. P., McSweeney, S. J., & Chapman, K. E. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0128 · Cited by 39
“11βHSD1 has low affinity for glucocorticoids (micromolar KM) relative to 11βHSD2, but where H6PDH is genetically deleted (Lavery et al. 2006) or where cells are disrupted so that NADPH cannot be generated in close proximity to 11βHSD1, it switches from predominantly oxoreductase to dehydrogenase activity and this…”
BackgroundMarcolongo, P., Piccirella, S., Senesi, S., Wunderlich, L., Gerin, I., Mandl, J., Fulceri, R., Bánhegyi, G., & Benedetti, A. (2007) · Endocrinology · doi:10.1210/en.2006-1472 · Cited by 44
Stimson, R. H., & Walker, B. R. (2013) · hmbci · doi:10.1515/hmbci-2013-0015 · Cited by 38
“H6PDH generates the NADPH required for 11β-reductase activity, and H6PDH knockout mice have no 11β-reductase activity [33].”
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 47
Steroids - From Physiology to Clinical Medicine
Ostojić, S. M. (2012) · InTech eBooks · doi:10.5772/46119 · Cited by 41
“[59] Settembre C, Annunziata I, Spampanato C, Zarcone D, Cobellis G, Nusco E, Zito E, Tacchetti C, Cosma MP, Ballabio A.”
BackgroundInfluentialLavery, G. G., Hauton, D., Hewitt, K. N., Brice, S. M., Sherlock, M., Walker, E. A., & Stewart, P. M. (2007) · Endocrinology · doi:10.1210/en.2007-0963 · Cited by 43
Self-citationZhang, Y., Zhong, X., Gjoka, Z., Li, Y., Stochaj, W. R., Stahl, M., Kriz, R., Tobin, J. F., Erbe, D. V., & Suri, V. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.12.004 · Cited by 44
MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing’s syndrome
Morgan, S., Hassan-Smith, Z. K., & Lavery, G. G. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1237 · Cited by 39
Self-citationAlterations of Cortisol Metabolism in Human Disorders
White, P. C. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485508 · Cited by 39
Self-citationMitić, T., Shave, S., Semjonous, N. M., McNae, I. W., Cobice, D., Lavery, G. G., Webster, S. P., Hadoke, P. W. F., Walker, B. R., & Andrew, R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.002 · Cited by 39
“Protein concentrations were quantified using a BioRad kit (Hemel Hempstead, UK).”
Self-citationZhou, X., Yang, H. Y., Yan, Q., Ren, A., Kong, Z., Tang, S., Han, X., Tan, Z., & Salem, A. Z. M. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0346-7 · Cited by 34
Kim, S. Y., Nguyen, A. D., Gao, J., Murphy, P. M., Mansfield, B. C., & CHOU, J. Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604964200 · Cited by 33
Chinetti, G., Bouhlel, M. A., Copin, C., Duhem, C., Derudas, B., Neve, B., Noel, B., Eeckhoute, J., Lefèbvre, P., Seckl, J. R., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.241364 · Cited by 35
Chan, J., Rabbitt, E. H., Innes, B. A., Bulmer, J. N., Stewart, P. M., Kilby, M. D., & Hewison, M. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0289 · Cited by 34
Self-citationTorrecilla, E., Fernández‐Vázquez, G., Vicent, D., Sánchez‐Franco, F., Barabash, A., Cabrerizo, L., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0524-9 · Cited by 35
Turban, S., Liu, X., Ramage, L., Webster, S. P., Walker, B. R., Dunbar, D. R., Mullins, J. J., Seckl, J. R., & Morton, N. M. (2012) · Diabetes · doi:10.2337/db11-1054 · Cited by 31
Relative adrenal insufficiency in mice deficient in 5α-reductase 1
Livingstone, D. E. W., Rollo, E. M. D., Yang, C., Lucy, C., Mathews, J. A., Kara, M., Hughes, K. A., Kenyon, C. J., Walker, B. R., & Andrew, R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0563 · Cited by 37
“In contrast, mice unable to regenerate tissue glucocorticoids due to deletion of Hsd11b1 or hexose-6-phosphate dehydrogenase exhibit adrenal hypertrophy (Kotelevtsev et al. 1997, Harris et al. 2001, Lavery et al. 2006, Carter et al. 2009).”
BackgroundCao, X., Lilla, S., Cao, Z., Pringle, M. A., Oka, O., Robinson, P. J., Szmaja, T., van Lith, M., Zanivan, S. R., & Bulleid, N. J. (2020) · Journal of Cell Science · doi:10.1242/jcs.241976 · Cited by 27
“As there is an ER-localised hexose 6-phosphate dehydrogenase (Lavery et al., 2006), G6Pmight enter the ER via the G6P-transporter, be metabolised to phosphogluconolactone and in the process regenerate the ER pool of NADPH.”
BackgroundLi, J., Berk, M. P., Alyamani, M., Sabharwal, N., Goins, C. M., Alvarado, J., Baratchian, M., Zhu, Z., Stauffer, S. R., Klein, E. A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe8226 · Cited by 33
Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T. C., & Liu, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1956-9 · Cited by 29
Zhu, L., Hou, M., Sun, B., Burén, J., Zhang, L., Yi, J., Hernell, O., & Li, X. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2708 · Cited by 32
Boothby, M., McGee, K. C., Tomlinson, J., Gathercole, L., McTernan, P. G., Shojaee‐Moradie, F., Umpleby, A. M., Nightingale, P., & Shahmanesh, M. (2009) · Antiviral Therapy · doi:10.3851/imp1457 · Cited by 30
“Genes involved in glucocorticoid generation, essential for adipocyte differentiation were 11β-hydroxysteroid dehydrogenase type-1 (11βHSD-1), which regenerates the active glucocorticoid cortisol from inactive cortisone [11]; hexose 6-phosphate dehydrogenase (H6PDH), which generates the cofactor NADPH for 11βHSD-1 and…”
BackgroundLondon, E., Lala, G., Berger, R., Panzenbeck, A., Kohli, A., Renner, M., Jackson, A., Raynor, T., Loya, K., & Castonguay, T. W. (2007) · Journal of Nutrition · doi:10.1093/jn/137.12.2616 · Cited by 36
Kardon, T., Senesi, S., Marcolongo, P., Legeza, B., Bánhegyi, G., Mandl, J., Fulceri, R., & Benedetti, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.045 · Cited by 28
“Nevertheless, this effect has not been directly proven yet, and further work – eventually in G6PT [12] and H6PDH knockout mice [ 44 ] – is needed to clarify this point.”
ResultMarcolongo, P., Senesi, S., Gava, B., Fulceri, R., Sorrentino, V., Margittai, É., Lizák, B., Csala, M., Bánhegyi, G., & Benedetti, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.027 · Cited by 32
“The importance of H6PDH in this process has been demonstrated in H6PDH knockout mice, where the 11bHSD1 reductase activity disappeared, whereas dehydrogenase activity was increased [15]; consequently, glucose output and glucose utilization were abnormal resulting in fasting hypoglycemia [16].”
Background
Metadata
- Authors
- Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- The University of Texas Southwestern Medical Center (US)
- UCSF Benioff Children's Hospital (US)
- Corresponding author
- Stewart, Paul M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 281
- Issue
- 10
- Pages
- 6546-6551
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2033474018
- Semantic Scholar
- de686e1b3c804228c9bd624505f14d4110b08e9c
- Cited by
- 207
- References
- 30
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 10 · 2012: 15
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5361 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, 11-dehydrocorticosterone, NADPH production, endoplasmic reticulum, hepatic glucose production, visceral fat, metabolic syndrome
- MeSH terms
- Adrenal Glands, Animals, Carbohydrate Dehydrogenases, Female, Glucocorticoids, Kinetics, Male, Mice, Inbred C57BL, Microsomes, Liver, Sequence Deletion, Mice, Knockout, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.